Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Herpes Labialis Treatment Market is Poised to Expand at a Moderate CAGR of 4.6% Over 2017-2027: Future Market Insights

Future Market Insights
Posted on: 23 Mar 18
Herpes Labialis Treatment Market is Poised to Expand at a Moderate CAGR of 4.6% Over 2017-2027: Future Market Insights

PR Newswire

VALLEY COTTAGE, New York, March 23, 2018

VALLEY COTTAGE, New York, March 23, 2018 /PRNewswire/ --

Attributed to rising penetration of generics and innovations in disease treatment, the US$ 869.3 Mn global herpes labialis treatment market is anticipated to expand at a CAGR of 4.6% over 2017-2027, attaining a value worth US$ 1,358.7 Mn by 2027 end. Over a 10-year forecast period, the demand for herpes labialis treatment is likely to be driven by growing instances of viral infection worldwide and evolution of drug types and modes of action. Moreover, strategic M&A activities among leading industry players as well as amplifying investments in R&D ventures will also turn out to be profitable for the global herpes labialis treatment market during the assessment period.

     (Logo: http://photos.prnewswire.com/prnh/20161020/430874LOGO )

North America to Maintain Leading Regional Market Position 

Supported by strong presence of a few of the key industry players, North America's herpes labialis treatment market is expected to continue its dominance throughout the forecast period. While this region registered over 35% value share, Western Europe recorded a share of over 20% in 2017. North American region is presumed to exceed the revenues worth US$ 450 Mn by the end of 2027, observing a declining CAGR of 3.9%. Although the US will lead the North American region, Future Market Insights projects that Canada will witness higher adoption of herpes labialis treatment in the assessment period.  

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-6461

On the flipside, emerging regional markets such as APEJ, MEA, Eastern Europe, and Latin America will see rapid growth in the forecast period. APEJ is identified to be the fastest growing market at a promising CAGR of 5.7%, followed by MEA, predicted to grow at 5.3% CAGR over 2017-2027. Strengthening efforts and accelerating investments in the examination of the clinical efficacy of drugs, increasing expenditure on R&D infrastructure, growing consumer awareness, and development of advanced, cost-effective treatment options at a rapid pace, will collectively lift the market in emerging countries up. Moreover, lenient FDI policies that govern the pharmaceuticals industry in developing economies prompt at the inflow of a series of opportunities for drug companies to explore these regional markets in near future.

Preview Analysis on Global Herpes Labialis Treatment Market Segmentation By Dug Type - Acyclovir, Valacyclovir, Famciclovir, Penciclovir, Docosanol; By Route of administration Type - Topical, Oral; By Distribution channel Type - Hospital pharmacies, Retail pharmacies, Drug stores, Online pharmacies : https://www.futuremarketinsights.com/reports/herpes-labialis-treatment-market

Key Market Players 

Some of the leading players competing in the global herpes labialis treatment market include Novartis AG, Valeant Pharmaceuticals International Inc., Pfizer Inc., Abbott Laboratories, Mylan NV, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and GlaxoSmithKline plc. A majority of key players are directing their efforts towards extension of existing product portfolio, while others are focusing on strategic mergers and acquisitions in order to grab larger market shares in terms of revenue. Many top brands are looking forward to capitalize on growing opportunities in emerging regional markets.

Our advisory services are aimed at helping you with specific, customised insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-6461

More from FMI ' s Cutting-edge Intelligence: 

  • Radio Frequency Beauty Equipment Market Radio Frequency Beauty Equipment Market Segmentation By Product Type - Table Top, Trolley Mounted and Portable; By Technology - Mono-Polar Frequency, Bio-Polar Radio Frequency, Multi-Polar Radio Frequency and Fractional Radio Frequency; By Application - Skin Treatment (Skin Reconstruction, Scar Removal and Non-Surgical Skin Tightening), Body Contouring (Liposuction, Cellulite Reduction and Non-Surgical Fat Reduction) and Hair Removal; By End User - Beauty Care Centre and Home Care Settings: https://www.futuremarketinsights.com/reports/radio-frequency-beauty-equipment-market
  • Sleep Apnea Diagnostic System Market Sleep Apnea Diagnostic System Market Segmentation By Product Type - Polysomnography (PSG) Devices (Ambulatory PSG Monitoring Devices, Clinical PSG Monitoring Devices), Sleep Apnea Screening Devices (Nasal Flow Sensors, Peripheral Capillary Oxygen Saturation (SPO2)) and Actigraphy Monitoring Devices; By End User - Home Care Settings, Hospitals, Sleep Centres and Clinics: https://www.futuremarketinsights.com/reports/sleep-apnea-diagnostic-system-market
  • Excimer and Femtosecond Ophthalmic Lasers Market Excimer and Femtosecond Ophthalmic Lasers Market Segmentation By Product - Excimer Lasers and Femtosecond Lasers; By Application - Refractive Surgery, Cataract Surgery, Capsulotomy, Trabeculoplasty and Diagnostics; By End User - Hospitals, Ophthalmology Clinics and Ambulatory Surgical Centres: https://www.futuremarketinsights.com/reports/excimer-femtosecond-ophthalmic-lasers-market

About Us 

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Browse More Healthcare, Pharmaceuticals and Medical devices Market Insights

Contact Us
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44(0)20-7692-8790
Sales:sales@futuremarketinsights.com
Press Office: Press@futuremrketinsights.com

FMI Blog : http://www.fmiblog.com/

Website: http://www.futuremarketinsights.com


SOURCE Future Market Insights

PR Newswire
www.prnewswire.com

Last updated on: 23/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.